A new study, Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial, published in Lancet Psychiatry, the British medical journal may have duplicated Borge’s cousin’s success.
Article written by Richard Cowan, former NORML National Director and author of CBD Balm Salves.
When a politician or bureaucrat opposes something supported by over 90% of the American people, we are entitled to ask whom they really represent. The case in point is medical marijuana and the therapeutic use of other cannabinoids, specifically CBD.
Polls consistently show that almost all Americans favor legalizing medical marijuana and almost no one opposes allowing the use of CBD, which is not psychoactive. However, Mark Meadows, who represented North Carolina’s 11th District until he resigned on March 30, to become President Trump’s fourth Chief of Staff has consistently opposed any easing of Federal marijuana laws.